Investment Summary

Spring Mountain Capital Invests In AtlasXomics

On January 1, 2021, growth capital firm Spring Mountain Capital invested in life science company AtlasXomics

Investment Highlights
  • This is Spring Mountain Capital’s 5th transaction in the Life Science sector.
  • This is Spring Mountain Capital’s 22nd transaction in the United States.
  • This is Spring Mountain Capital’s 2nd transaction in Connecticut.

Investment Summary
Date 2021-01-01
Target AtlasXomics
Sector Life Science
Investor(s) Spring Mountain Capital
Deal Type Venture

Target

AtlasXomics

New Haven, Connecticut, United States
AtlasXomics is a commercializing novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases. AtlasXomics is based in New Haven, Connecticut.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Spring Mountain Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2001
Size Small
Type Sector Agnostic
DESCRIPTION

Spring Mountain Capital is a growth capital firm focused on providing expansion capital to tech-enabled companies across North America. The Firm looks to invest in earlier stage companies ($2 to $10 million of revenue) with high growth rates, proven products/services, and a path to profitability. Spring Mountain generally looks to commit $5 to $15 million per transaction. Spring Mountain Capital was formed in 2001 and is based in New York City.

DEAL STATS #
Overall 23 of 28
Sector (Life Science) 5 of 7
Type (Venture) 13 of 18
State (Connecticut) 2 of 2
Country (United States) 22 of 26
Year (2021) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-14 Aware

Columbus, Ohio, United States

Aware delivers AI-infused governance, compliance and monitoring for enterprise organizations deploying today’s leading collaboration and messaging platforms, including Slack, Microsoft Teams, Yammer and Workplace from Facebook. Aware’s comprehensive platform solves common challenges that legal, compliance, information security and IT departments face when rolling out collaboration, including archiving, monitoring, organization insights, DLP, eDiscovery, retention and legal holds. Aware is based in Columbus, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-08 Oncoceutics

Philadelphia, Pennsylvania, United States

Oncoceutics, Inc. is a clinical-stage biotechnology company developing imipridones, a novel class of compounds. Oncoceutics’ lead product candidate, ONC201, has been shown in clinical testing to selectively induce cell death in multiple cancer types. ONC201 is currently in a registrational clinical trial for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected in 2021. Oncoceutics, Inc. was founded in 2009 and is based in Philadelphia, Pennsylvania.

Sell $78M
Mergr

Product

Company

Legal